Back to search

National and Kapodistrian University of Athens

Μελέτη έκφρασης βιοδεικτών σε νεογνά με σύνδρομο αναπνευστικής δυσχέρειας

Abstract

dc:description

Objective: To determine the diagnostic accuracy of urinary NT-proBNP levels in the detection and classification of the severity of respiratory distress in neonates after birth. The detection of NT-proBNP levels in serum samples collected from healthy term neonates during the neonatal period. Methods: We compared the urinary NT- proBNP levels between the respiratory distress (RD) group and the control group on the 1st, 3rd, and 5th day of life (DOL). A systematic review of relevant literature in accordance with PRISMA guidelines was conducted. For quality appraisal, the potential risk of bias was assessed using the BIOCROSS evaluation tool. The random-effects and fixed-effects models were used to calculate weighted mean differences with a corresponding 95% confidence interval. Results: The RD group (55 neonates) showed higher levels of NT proBNP compared to the control group (63 neonates) on DOL1 (585.4 pg/ml vs 396.1 pg/ml (p=0.014)), DOL3 (805.1 pg/ml vs 271.9 pg/ml (p<0.001)) and DOL5 (409.7 pg/ml vs 94.4 pg/ml (p<0.001)). Especially, on DOL5, the area under the ROC curve was 0.884 and the NT-proBNP cut-off value (221.8 pg/ml) showed a sensitivity of 71% and specificity of 79%. The RD group was subclassified into neonates with mild (21 neonates), moderate (19 neonates), and severe (15 neonates) disease. NT-proBNP cut-off point of 668 pg/ml for DOL5 can safely differentiate neonates with severe disease from those with mild and moderate disease (combined subgroups) since the sensitivity was 80% and specificity was 77.5% for DOL5. A total of forty (40) studies met the inclusion criteria for the systematic review. After further examination fourteen (14) studies (393 participants) from the serum sample group were selected to perform a meta-analysis. Using the fixed-effects model, the mean interval of NT-proBNP in serum samples was 1341 pg/mL (95% CI: 1286–1397 pg/mL).Conclusion: Urinary NT-proBNP levels are a useful biomarker in detecting clinical signs of respiratory distress in neonates that are born within the first week of life; they can also detect neonates that are vulnerable to severe forms of the disease. Also, we present the intervals of NT-proBNP in the serum of healthy term neonates. The determination of the potential effect of perinatal factors on the biomarker’s reference range was also aimed.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2023

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Christou, Evangelos
  • Χρήστου, Ευάγγελος

Subjects

dc:subject × 16

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/54731

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Christou, Evangelos; Χρήστου, Ευάγγελος. Μελέτη έκφρασης βιοδεικτών σε νεογνά με σύνδρομο αναπνευστικής δυσχέρειας. National and Kapodistrian University of Athens, 2023. http://hdl.handle.net/10442/hedi/54731